GuideStar Eldercare published a blog exploring the risks of QT prolongation, arrhythmia, and cardiac death associated with second-generation antipsychotics like quetiapine.
Public source
Publisher name
Public post
Elderly patients taking quetiapine may be facing dangerous cardiac risk. So-called “second generation” antipsychotics like quetiapine (Seroquel) continue to be associate…
Company
GuideStar Eldercare
The leader in neuro-behavioral healthcare for geriatric and adult residents in long term care facilities.
- Industry
- Medical Practices
- Location
- Crown Point, US
- Company size
- 51–200 employees
About GuideStar Eldercare
GuideStar Eldercare is transforming dementia care in LTC facilities. We set the standard for modern psychiatric, psychological, and neurological services to our partner nursing homes and memory care facilities in the states of Indiana, Michigan, Texas, Kentucky, Ohio, and Tennessee. The GuideStar Eldercare Long-Term Care Antipsychotic Stewardship™ aims to reduce the usage of unnecessary medication for residents with dementia and psychiatric conditions and provides positive clinical outcomes for residents and support for LTC facilities.
See moreLatest activity
Latest activity from GuideStar Eldercare
5 signals
Partnerships
GuideStar Eldercare believes its partner organizations deserve a collaborative, integrated approach that brings neurology, psychiatry, psychology, and the broader care team together around the resident.
Presence & Recognition
GuideStar Eldercare published a blog review of the current clinical and regulatory landscape for long-term care and neurology-forward approaches.
Presence & Recognition
GuideStar Eldercare is attending the Pennsylvania Health Care Association Convention & Expo in two weeks for James Shackson's presentation on neurology-informed care and compliance.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Core Prescribing Solutions
Core Prescribing Solutions noted that NICE has updated its psychosis and schizophrenia guideline, clarifying antipsychotic medication terminology.
Research & Knowledge
Metabolic Psychiatry Labs, Inc.
Metabolic Psychiatry Labs, Inc. published a new feature in Medscape exploring the role of ketogenic metabolic therapy in treating severe mental illness.
Research & Knowledge
Alzheimer's Los Angeles
Alzheimer's Los Angeles published a commentary in the Journal of the American Geriatrics Society titled 'The Pitt, the Beers Criteria, and a Long-Overdue Prime-Time Moment for Geriatric Medicine'
Research & Knowledge
Advantage Healthcare Services
Advantage Healthcare Services published patient data comparing the median antipsychotic therapy duration to a published U.S. benchmark from the University of Minnesota College of Pharmacy analysis.
Research & Knowledge
FinallyLivingNow